Microsimulation projections of obesity interventions on cardiometabolic health disparities in the United States.
Where this comes from
- Record sourced from PubMed, PMID 34932883.
- Also identified by DOI 10.1002/oby.23297 and PMC identifier 8711610.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The aim of this study was to estimate long-term impacts of health education interventions on cardiometabolic health disparities. The model simulates how health education implemented in the United States throughout 2019 to 2049 would lead to changes in adult BMI and consequent hypertension and type 2 diabetes. Health outcome changes by sex, racial/ethnic (non-Hispanic White, non-Hispanic Black, and Hispanic), and weight status (normal: 18.5 <math xmlns="http://www.w3.org/1998/Math/MathML"><mo>≤</mo></math> BMI < 25; overweight: 25 <math xmlns="http://www.w3.org/1998/Math/MathML"><mo>≤</mo></math> BMI < 30; and obesity: 30 <math xmlns="http://www.w3.org/1998/Math/MathML"><mo>≤</mo></math> BMI) subpopulations were compared under a scenario with and one without health education. By 2049, the intervention would reduce average BMI of women with obesity to 27.7 kg/m<sup>2</sup> (CI: 27.4-27.9), which would be 2.9 kg/m<sup>2</sup> lower than the expected average BMI without an intervention. Education campaigns would reduce type 2 diabetes prevalence, but it would remain highest among women with obesity at 27.7% (CI: 26.2%-29.2%). The intervention would reduce hypertension prevalence among White women by 4.7 percentage points to 38.0% (CI: 36.4%-39.7%). For Black women in the intervention, the 2049 hypertension prevalence would be 52.6% (CI: 50.7%-54.5%). Results for men and women were similar. Long-term health education campaigns can reduce obesity-related disease. All population groups benefit, but they would not substantially narrow cardiometabolic health disparities.
Medical subject headings
- Cardiovascular Diseases
- Diabetes Mellitus, Type 2